Furthermore, PFKP was reported to be associated with epithelial–mesenchymal transition in BC cells, and its overexpression is a poor prognostic factor for BC patients with BRCA1 deficiency (Kim et al., 2017). This evidence concerns the gene PFKP and breast cancer.